Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.41 EUR
−54.68 M EUR
14.92 M EUR
61.76 M
About AC Immune SA
Sector
CEO
Andrea Pfeifer
Headquarters
Lausanne
Website
Founded
2003
ISIN
CH0329023102
FIGI
BBG00DY40RF9
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMR is 3.19 EUR — it has increased by 2.38% in the past 24 hours. Watch AC IMMUNE LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange AC IMMUNE LTD stocks are traded under the ticker IMR.
IMR stock has risen by 3.86% compared to the previous week, the month change is a 18.10% rise, over the last year AC IMMUNE LTD has showed a 9.81% increase.
We've gathered analysts' opinions on AC IMMUNE LTD future price: according to them, IMR price has a max estimate of 15.17 EUR and a min estimate of 7.25 EUR. Watch IMR chart and read a more detailed AC IMMUNE LTD stock forecast: see what analysts think of AC IMMUNE LTD and suggest that you do with its stocks.
IMR stock is 2.54% volatile and has beta coefficient of 1.18. Track AC IMMUNE LTD stock price on the chart and check out the list of the most volatile stocks — is AC IMMUNE LTD there?
Today AC IMMUNE LTD has the market capitalization of 317.50 M, it has increased by 3.78% over the last week.
Yes, you can track AC IMMUNE LTD financials in yearly and quarterly reports right on TradingView.
AC IMMUNE LTD is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
IMR earnings for the last quarter are 0.05 EUR per share, whereas the estimation was −0.14 EUR resulting in a 136.61% surprise. The estimated earnings for the next quarter are −0.20 EUR per share. See more details about AC IMMUNE LTD earnings.
AC IMMUNE LTD revenue for the last quarter amounts to 27.01 M EUR, despite the estimated figure of 7.70 M EUR. In the next quarter, revenue is expected to reach 1.31 M EUR.
IMR net income for the last quarter is 5.70 M EUR, while the quarter before that showed −23.49 M EUR of net income which accounts for 124.28% change. Track more AC IMMUNE LTD financial stats to get the full picture.
No, IMR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2024, the company has 161.00 employees. See our rating of the largest employees — is AC IMMUNE LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AC IMMUNE LTD EBITDA is −35.74 M EUR, and current EBITDA margin is −357.37%. See more stats in AC IMMUNE LTD financial statements.
Like other stocks, IMR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AC IMMUNE LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AC IMMUNE LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AC IMMUNE LTD stock shows the buy signal. See more of AC IMMUNE LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.